Want to join the conversation?
$TOL expects FY16 revenues of $4.96-5.27Bil, up about 19-26% over FY15. The company lowered FY16 adjusted gross margin outlook to 25.6-25.8% from prior forecast of 25.8-26.2%, and its FY16 other income and income from unconsolidated entities guidance to $88.5-93.5MM from prior estimate of $105-130MM.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)